rs397507954
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
G
0.700
CausalMutation
CLINVAR
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
31131967
2019
rs397507954
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
G
0.700
CausalMutation
CLINVAR
Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
28339459
2017
rs397507954
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
G
0.700
CausalMutation
CLINVAR
Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls.
28111427
2017
rs397507954
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
G
0.700
CausalMutation
CLINVAR
Detection of Germline Mutation in Hereditary Breast and/or Ovarian Cancers by Next-Generation Sequencing on a Four-Gene Panel.
27157322
2016
rs397507954
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
G
0.700
CausalMutation
CLINVAR
Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
27741520
2016
rs397507954
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
G
0.700
CausalMutation
CLINVAR
Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing.
26757417
2016
rs397507954
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
G
0.700
CausalMutation
CLINVAR
BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer.
26439132
2016
rs397507954
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
G
0.700
CausalMutation
CLINVAR
Prevalence and differentiation of hereditary breast and ovarian cancers in Japan.
24249303
2015
rs397507954
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
G
0.700
CausalMutation
CLINVAR
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations.
25348012
2014
rs397507954
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
G
0.700
CausalMutation
CLINVAR
Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain).
23683081
2013
rs397507954
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
G
0.700
CausalMutation
CLINVAR
Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants.
22505045
2012
rs397507954
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
G
0.700
CausalMutation
CLINVAR
The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.
18703817
2008
rs397507954
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
G
0.700
CausalMutation
CLINVAR
Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
18424508
2008